Teen beaten by rare kidney cancer graduates high school after years of treatment

A teenager once told he might not survive the year walked across the stage at Kansas City Christian School with the doctor who helped pull him through stage 4 kidney cancer in the crowd. Dylan Mwaniki, diagnosed at 14, graduated in Kansas City, Missouri, after years of treatment for renal medullary carcinoma, one of the rarest and most aggressive forms of kidney cancer.

The diagnosis came in May 2022, when doctors told the Mwaniki family the odds were grim and Dylan may have had only a year to live. Later, they were given an even tighter estimate of about eight months. Instead, Dylan endured surgeries and 52 weeks of chemotherapy, making repeated trips from Missouri to Texas as he chased care at MD Anderson Cancer Center in Houston.

Renal medullary carcinoma was first described in 1995, according to the National Cancer Institute, and MD Anderson says it is usually found in younger Black people in the United States. Medical literature has described it as accounting for less than 1% of kidney tumors. That rarity matters: families confronting the disease often face limited treatment experience, urgent decisions and the burden of traveling long distances to reach specialists who have seen it before.

Mary Austin, then a pediatric surgical oncologist at MD Anderson, became central to Dylan’s care after meeting him just after his eighth-grade year. She later moved to Seattle Children’s Hospital, but the relationship followed Dylan well beyond the operating room. Dylan’s parents, Luci and Paul Mwaniki, said Austin became more than a doctor. Dylan called her his “second mom,” and his parents said she checked on him like a mother would. Before one especially difficult stretch of treatment, Austin promised Dylan that if he made it to graduation, she would be there.

She kept that promise. Austin flew 1,500 miles from Washington state after working overnight and rearranging her surgical schedule to attend the May 17, 2026, ceremony. Dylan had been declared cancer-free in September 2024, and the graduation hug between patient and doctor, captured on video by family friend Kevin LaBranche, spread quickly online. The scene struck a nerve because it showed more than survival. It showed how rare-cancer care can depend on long-distance access, relentless treatment and a support system strong enough to carry a teenager from a life-threatening diagnosis to a diploma.